{"id":4110,"date":"2015-01-03T15:24:30","date_gmt":"2015-01-03T15:24:30","guid":{"rendered":"http:\/\/ac-society.org\/wp\/?page_id=4110"},"modified":"2015-01-12T22:14:46","modified_gmt":"2015-01-12T22:14:46","slug":"panel-commentary-videos","status":"publish","type":"page","link":"https:\/\/ac-society.org\/wp\/en\/initiatives\/atlantic-antiplatelet-initiative-aapi\/videos\/panel-commentary-videos\/","title":{"rendered":"AAPI Panel Commentary Videos"},"content":{"rendered":"\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-d6c3a2083b710e6d55e858cf822ebd6b\">\n#top .av-special-heading.av-av_heading-d6c3a2083b710e6d55e858cf822ebd6b{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-d6c3a2083b710e6d55e858cf822ebd6b .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-d6c3a2083b710e6d55e858cf822ebd6b .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-d6c3a2083b710e6d55e858cf822ebd6b av-special-heading-h3  avia-builder-el-0  el_before_av_two_third  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Atlantic Anti-Platelet Guidelines Panel Commentary Videos<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div>\n<div class='flex_column av-av_two_third-2a9015ff38129c418a3f2eafba3e9512 av_two_third  avia-builder-el-1  el_after_av_heading  el_before_av_one_third  first flex_column_div '     ><section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><p>The primary goal of the Atlantic Anti-Platelet Initiative (AAPI) was to develop evidence-based guidelines for the acute administration of oral anti-platelet therapy in patients presenting with ACS throughout Atlantic Canada. Although dual anti-platelet therapy with aspirin and clopidogrel is well established as the regional standard of care, uncertainty exists regarding how the novel P2Y12 inhibitors prasugrel and ticagrelor should be incorporated into clinical practice.<\/p>\n<p>The AAPI recommendations differ from both the National CCS and ESC guidelines based primarily on the typical demographics of the Atlantic Canada ACS patient population. Please take the time to review the AAPI Panelist video\u2019s where insight on the factors that influenced their decision-making are presented.<\/p>\n<\/div><\/section><\/div>\n<div class='flex_column av-av_one_third-3d629b6c2a646979d79593678077f00c av_one_third  avia-builder-el-3  el_after_av_two_third  el_before_av_one_third  flex_column_div '     ><style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_image-9008d4ad2e0e796557e8c1a487dc14b3\">\n.avia-image-container.av-av_image-9008d4ad2e0e796557e8c1a487dc14b3 img.avia_image{\nbox-shadow:none;\n}\n.avia-image-container.av-av_image-9008d4ad2e0e796557e8c1a487dc14b3 .av-image-caption-overlay-center{\ncolor:#ffffff;\n}\n<\/style>\n<div  class='avia-image-container av-av_image-9008d4ad2e0e796557e8c1a487dc14b3 av-styling- avia-align-center  avia-builder-el-4  avia-builder-el-no-sibling '   itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" ><div class=\"avia-image-container-inner\"><div class=\"avia-image-overlay-wrap\"><img decoding=\"async\" class='wp-image-4180 avia-img-lazy-loading-not-4180 avia_image ' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/acs-api-logo.png\" alt='' title='acs-api-logo'  height=\"120\" width=\"272\"  itemprop=\"thumbnailUrl\"  \/><\/div><\/div><\/div><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-5  el_after_av_one_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-a9453cf3b78b0881b2be76b6c0038374  avia-builder-el-6  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4114 avia-img-lazy-loading-not-4114 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-michael-love.jpg\" alt='Michael P. Love '  itemprop=\"image\"   height=\"360\" width=\"480\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-michael-love.jpg 480w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-michael-love-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-michael-love-300x225.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Michael P. Love <\/h3><div class='team-member-job-title '  itemprop=\"jobTitle\" >MD, MB, ChB, MRCP<\/div><div class='team-member-description '  itemprop=\"description\" ><p>Interventional Cardiologist<br \/>\nAAPI Steering Committee Chair<br \/>\nQueen Elizabeth II Health Sciences Centre<br \/>\nHalifax, Nova Scotia<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-7  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-a838e704defad9cf845334b26017cf05\">\n#top .av-special-heading.av-av_heading-a838e704defad9cf845334b26017cf05{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-a838e704defad9cf845334b26017cf05 .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-a838e704defad9cf845334b26017cf05 .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-a838e704defad9cf845334b26017cf05 av-special-heading-h3  avia-builder-el-8  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Michael P. Love MD, MB, ChB, MRCP<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/zOhGbda7uto?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What drove the decision to create Atlantic acute coronary syndrome guideline?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/N4LQK-3YLB4?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What body of clinical evidence did the Panel review and consider while forming the recommendations and how were subgroup analyses utilized?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/GB0OY3DsVMU?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">The AAPI Guideline primarily recommends a Selective vs. Universal approach to the use of the newer antiplatelet medications, what considerations influenced that decision?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/LI_ZXebNr9Y?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What body of evidence was used to support a switch between antiplatelet agents?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/OjaMMKuZHyI?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What role do you foresee for Inter-Provincial clinical committees such as these during the reimbursement process?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/XmFO843i278?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What are the key messages the Panel would like to share with Atlantic clinicians via the AAPI recommendations?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-10  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-4c68d5944651f7efc0bf3da0359f0bcf  avia-builder-el-11  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4120 avia-img-lazy-loading-not-4120 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-vernon-paddock.jpg\" alt='Vernon Paddock'  itemprop=\"image\"   height=\"360\" width=\"480\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-vernon-paddock.jpg 480w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-vernon-paddock-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-vernon-paddock-300x225.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Vernon Paddock<\/h3><div class='team-member-job-title '  itemprop=\"jobTitle\" >MD, FRCPC<\/div><div class='team-member-description '  itemprop=\"description\" ><p>Interventional Cardiologist &amp; Chief of Cardiology<br \/>\nSaint John Regional Hospital<br \/>\nSaint John, New Brunswick<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-12  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-4d2a1f1250b5e9ce1c6f641162a4d1f3\">\n#top .av-special-heading.av-av_heading-4d2a1f1250b5e9ce1c6f641162a4d1f3{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-4d2a1f1250b5e9ce1c6f641162a4d1f3 .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-4d2a1f1250b5e9ce1c6f641162a4d1f3 .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-4d2a1f1250b5e9ce1c6f641162a4d1f3 av-special-heading-h3  avia-builder-el-13  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Vernon Paddock MD, FRCPC<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/eKu8a5dS3xE?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Why was there a need to create an Atlantic acute coronary syndrome guideline?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/gZzzMCDE8PM?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What body of clinical evidence did the Panel review and consider during recommendation decision-making?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/U_HLDI15oeI?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What evidence was used to support a switch between antiplatelet agents?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/qWy-GZFl1nI?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What role do you foresee for inter-Provincial clinical committees such as these during the reimbursement process?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/97V1Lcvnh8I?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">The AAPI Guideline primarily recommends a Selective vs. Universal approach when prescribing the newer antiplatelet medications, what factors influenced that decision?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/LYJby3ygknQ?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Appreciating there was consensus between AAPI Panel members, was there similar agreement by Secondary Panelists who reviewed the recommendations?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/aFT7c1JtG4o?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Why do the AAPI recommendations differ from the National CCS Antiplatelet and ECS guidelines if each of the committee\u2019s evaluated the same body of clinical evidence?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-15  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-60d5805edf83160667de4edb5023ff4b  avia-builder-el-16  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4140 avia-img-lazy-loading-not-4140 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-barry-rose.jpg\" alt='Barry Rose'  itemprop=\"image\"   height=\"360\" width=\"480\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-barry-rose.jpg 480w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-barry-rose-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-barry-rose-300x225.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Barry Rose<\/h3><div class='team-member-job-title '  itemprop=\"jobTitle\" >MD, FRCPC, FACC<\/div><div class='team-member-description '  itemprop=\"description\" ><p>Barry Rose MD, FRCPC, FACC<br \/>\nInterventional Cardiologist<br \/>\nChief of Cardiology (Eastern Health)<br \/>\nAssistant Professor, Memorial University<br \/>\nSt. John\u2019s, Newfoundland<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-17  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-b0e8b2809af12d01fd200c77339a80b5\">\n#top .av-special-heading.av-av_heading-b0e8b2809af12d01fd200c77339a80b5{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-b0e8b2809af12d01fd200c77339a80b5 .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-b0e8b2809af12d01fd200c77339a80b5 .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-b0e8b2809af12d01fd200c77339a80b5 av-special-heading-h3  avia-builder-el-18  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Barry Rose MD, FRCPC, FACC<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/Wjd89tmuaHs?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Why was there a need to create an Atlantic acute coronary syndrome guideline?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/CKaTd4Hu_2E?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">The AAPI Guideline primarily recommends a Selective vs. Universal approach when using the newer antiplatelet medications, what considerations influenced that decision?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/crpD-holSDU?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What evidence was used to support a switch between antiplatelet medications?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/XBiuhFhJVOI?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Appreciating there was consensus between AAPI Panel members, was there similar agreement by Secondary Panelists?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/KPYlINnDodU?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What role do you foresee for Inter-Provincial clinical committees such as these during the reimbursement process?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/ugW5waXMJ_E?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What are the key messages the Panel would like to share with Atlantic clinicians via the AAPI recommendations?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-20  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-ee2a35e52c984f2a127aa4a59a22f776  avia-builder-el-21  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4142 avia-img-lazy-loading-not-4142 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-michel-dastou.jpg\" alt='Michel D\u2019Astou'  itemprop=\"image\"   height=\"360\" width=\"480\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-michel-dastou.jpg 480w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-michel-dastou-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-michel-dastou-300x225.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Michel D\u2019Astou<\/h3><div class='team-member-job-title '  itemprop=\"jobTitle\" >MD, FRCPC<\/div><div class='team-member-description '  itemprop=\"description\" ><p>Clinical Professor, Sherbrooke University<br \/>\nCardiologie \u2014 Dr. Georges L. Dumont Hospital<br \/>\nMoncton, New Brunswick<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-22  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-ee4b5047c08a004c035b8d195f7824cd\">\n#top .av-special-heading.av-av_heading-ee4b5047c08a004c035b8d195f7824cd{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-ee4b5047c08a004c035b8d195f7824cd .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-ee4b5047c08a004c035b8d195f7824cd .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-ee4b5047c08a004c035b8d195f7824cd av-special-heading-h3  avia-builder-el-23  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Michel D\u2019Astou MD, FRCPC<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/w8QQxxZCr4g?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Pourquoi y avait-il un besoin de cr\u00e9er des lignes directrices sur les syndromes coronariens aigus (SCA) au Canada atlantique?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/fGmBMhO8-Lk?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Comment la r\u00e9gion de l\u2019Atlantique \u00e9tait-elle repr\u00e9sent\u00e9e dans la composition du comit\u00e9 AAPI?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/Kd0wToJWwZI?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Du point de vue d\u2019un cardiologue, comment qualifieriez-vous le processus d\u2019\u00e9laboration des lignes directrices de l\u2019AAPI?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/90yUPDLWrVw?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Pourquoi les recommandations de l\u2019AAPI diff\u00e8rent-elles des lignes directrices nationales de la SCC sur les antiplaquettaires ainsi que celles de la SEC, \u00e9tant donn\u00e9 que les m\u00eames preuves cliniques ont \u00e9t\u00e9 \u00e9valu\u00e9es?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/6ZDMKucxKpw?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Il semblerait que vos recommandations visent principalement \u00e0 appuyer l\u2019utilisation continue de Clopidogrel chez les patients atteints du SCA au Canada atlantique. Compte tenu des donn\u00e9es sup\u00e9rieures sur la mortalit\u00e9, pourquoi les nouveaux antiplaquettaires n\u2019ont-ils pas occup\u00e9 une place plus importante dans les lignes directrices?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/GocS2B_feDU?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Quels sont les messages cl\u00e9s que le comit\u00e9 voudrait transmettre aux cliniciens du Canada atlantique par l\u2019entremise des recommandations de l&#8217;AAPI?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-25  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-4e395da992969c24377f421e03f23623  avia-builder-el-26  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4144 avia-img-lazy-loading-not-4144 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/mike-callaghan.jpg\" alt='Mike Callaghan'  itemprop=\"image\"   height=\"360\" width=\"480\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/mike-callaghan.jpg 480w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/mike-callaghan-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/mike-callaghan-300x225.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Mike Callaghan<\/h3><div class='team-member-job-title '  itemprop=\"jobTitle\" >BSc. (Pharm)<\/div><div class='team-member-description '  itemprop=\"description\" ><p>Michael Callaghan BSc. (Pharm)<br \/>\nClinical Pharmacist in Cardiology<br \/>\nCapital District Health Authority<br \/>\nHalifax, Nova Scotia<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-27  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-54b54e6f13236aafb2c859a5631a4ff3\">\n#top .av-special-heading.av-av_heading-54b54e6f13236aafb2c859a5631a4ff3{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-54b54e6f13236aafb2c859a5631a4ff3 .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-54b54e6f13236aafb2c859a5631a4ff3 .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-54b54e6f13236aafb2c859a5631a4ff3 av-special-heading-h3  avia-builder-el-28  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Mike Callaghan BSc. (Pharm)<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/gHs00_LbLr4?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">As a Hospital Pharmacist, how would you characterize the process through which these recommendations were generated?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/fOvRXK4ihZw?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How do these recommendations impact care within and between hospitals throughout Atlantic Canada?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/-m0HnVMBvck?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Considering the mortality benefit, why did the Panel not recommended a broader use of the newer antiplatelet agents such as ticagrelor in emergency departments throughout Atlantic Canada?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/0B0hbaBLlwA?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Considering clopidogrel\u2019s inter-patient variability of antiplatelet effect and prominence of that molecule throughout the AAPI recommendations, how confident was your Panel with generic clopidogrel being prescribed for ACS patients?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/FBRBEUGhIhs?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How do payers throughout Atlantic Canada view the AAPI recommendations?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-30  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-84007e679d4e6d54facb3b5a1da16d4e  avia-builder-el-31  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4146 avia-img-lazy-loading-not-4146 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/rachel-harris.jpg\" alt='Rachel Harris'  itemprop=\"image\"   height=\"360\" width=\"480\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/rachel-harris.jpg 480w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/rachel-harris-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/rachel-harris-300x225.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Rachel Harris<\/h3><div class='team-member-job-title '  itemprop=\"jobTitle\" >BSc. (Pharm), PharmD.<\/div><div class='team-member-description '  itemprop=\"description\" ><p>Rachel Harris BSc. (Pharm), PharmD.<br \/>\nClinical Pharmacist in Cardiology<br \/>\nSaint John Regional Hospital<br \/>\nSaint John, New Brunswick<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-32  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-9a0c5708f9e8a5badfa4da6ba0131ede\">\n#top .av-special-heading.av-av_heading-9a0c5708f9e8a5badfa4da6ba0131ede{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-9a0c5708f9e8a5badfa4da6ba0131ede .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-9a0c5708f9e8a5badfa4da6ba0131ede .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-9a0c5708f9e8a5badfa4da6ba0131ede av-special-heading-h3  avia-builder-el-33  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Rachel Harris BSc. (Pharm), PharmD.<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/FK1bNnVn5X4?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">As a Hospital Pharmacist, how would you describe the process through which these recommendations were generated?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/IJYViq2A5dE?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How do these recommendations impact care within and between hospitals throughout Atlantic Canada?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/7H9xDDdZoIc?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Considering the mortality benefit, why did the Panel not recommended a broader use of the newer antiplatelet agents such as ticagrelor in emergency departments throughout Atlantic Canada?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/1QYd62ShoyI?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Considering clopidogrel\u2019s established inter-patient variability and prominence of that molecule within the AAPI recommendations, how confident was your Panel with generic clopidogrel being prescribed for acute coronary syndrome patients?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/dQxLD2HOzRo?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How do payers throughout Atlantic Canada view the AAPI recommendations?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-35  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-ab49842dcbc3551f68ab9a01bfd579cf  avia-builder-el-36  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4150 avia-img-lazy-loading-not-4150 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/kim-kelly.jpg\" alt='Kim D Kelly'  itemprop=\"image\"   height=\"360\" width=\"480\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/kim-kelly.jpg 480w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/kim-kelly-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/kim-kelly-300x225.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Kim D Kelly<\/h3><div class='team-member-job-title '  itemprop=\"jobTitle\" >BSc. (Pharm)<\/div><div class='team-member-description '  itemprop=\"description\" ><p>Drug Evaluation Unit Pharmacist<br \/>\nCapital District Health Authority<br \/>\nHalifax, Nova Scotia<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-37  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-35fa2e2be3794f09064aa4151d007f21\">\n#top .av-special-heading.av-av_heading-35fa2e2be3794f09064aa4151d007f21{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-35fa2e2be3794f09064aa4151d007f21 .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-35fa2e2be3794f09064aa4151d007f21 .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-35fa2e2be3794f09064aa4151d007f21 av-special-heading-h3  avia-builder-el-38  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Kim D Kelly BSc. (Pharm)<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/bgaGjYTpiyQ?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">As a Hospital Pharmacist, how would you describe the process through which these recommendations were generated?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/ipkAoI9I-tI?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How do these recommendations impact care within and between hospitals throughout Atlantic Canada<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/h13F1_R_J2U?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Considering the mortality benefit, why did the Panel not recommended a broader use of the newer antiplatelet agents such as ticagrelor in emergency departments throughout Atlantic Canada?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/_Hf7xxaAabw?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Considering clopidogrel\u2019s established inter-patient variability and prominence of that molecule within the AAPI recommendations, how confident was your Panel with generic clopidogrel being prescribed for acute coronary syndrome patients?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/Cq3o_QfVwzA?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Do payers from throughout Atlantic Canada hold an opinion on the AAPI recommendations?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-40  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-ac84699af1ba793cb38a160a9847123c  avia-builder-el-41  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4152 avia-img-lazy-loading-not-4152 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-david-marr-300x225.jpg\" alt='David Marr '  itemprop=\"image\"   height=\"225\" width=\"300\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-david-marr-300x225.jpg 300w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-david-marr-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-david-marr.jpg 480w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >David Marr <\/h3><div class='team-member-job-title '  itemprop=\"jobTitle\" >MD, FRCPC, FACC<\/div><div class='team-member-description '  itemprop=\"description\" ><p>Associate Professor, Memorial and Dalhousie Universities<br \/>\nCardiologist, Saint John Regional Hospital<br \/>\nSaint John, New Brunswick<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-42  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-8817cece1ca8365c5dbb197812310455\">\n#top .av-special-heading.av-av_heading-8817cece1ca8365c5dbb197812310455{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-8817cece1ca8365c5dbb197812310455 .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-8817cece1ca8365c5dbb197812310455 .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-8817cece1ca8365c5dbb197812310455 av-special-heading-h3  avia-builder-el-43  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >David Marr MD, FRCPC, FACC<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/G7zqXbeptTo?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">From a cardiologist\u2019s perspective, how would you describe the guideline development process?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/WjmhXCqTcao?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Why did the Atlantic Cardiovascular Society decide to endorse this Initiative and what role did it play?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/nMdftP3FHNo?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Considering the common body of published clinical evidence, why do the AAPI recommendations differ from the National CCS Antiplatelet and ECS guidelines?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/mOb7cox0K60?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What is the Provincial payer stance on the AAPI recommendations?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/URBOAPY4DG0?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What are the practical messages community physicians should consider when applying the AAPI recommendations?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-45  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-6dd21fc1103250420a0903b079600d74  avia-builder-el-46  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4154 avia-img-lazy-loading-not-4154 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-neil-pearce-300x225.jpg\" alt='Neil Pearce'  itemprop=\"image\"   height=\"225\" width=\"300\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-neil-pearce-300x225.jpg 300w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-neil-pearce-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-neil-pearce.jpg 480w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Neil Pearce<\/h3><div class='team-member-job-title '  itemprop=\"jobTitle\" >MD, FRCPC<\/div><div class='team-member-description '  itemprop=\"description\" ><p>Interventional Cardiologist &amp; Director of the Cardiac Catheterization laboratory (Eastern Health)<br \/>\nAssistant Professor, Memorial University<br \/>\nSt. John\u2019s, Newfoundland<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-47  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-2d92b2e153901c95780f0fe9665c9a29\">\n#top .av-special-heading.av-av_heading-2d92b2e153901c95780f0fe9665c9a29{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-2d92b2e153901c95780f0fe9665c9a29 .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-2d92b2e153901c95780f0fe9665c9a29 .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-2d92b2e153901c95780f0fe9665c9a29 av-special-heading-h3  avia-builder-el-48  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Neil Pearce MD, FRCPC<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/ubgWxg8mvuQ?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">As a Cardiologist how would you portray the guideline development process?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/n3_II2_rh2c?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What body of clinical evidence did the Panel review and consider during the development of the recommendations?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/aUJxRRTzcFM?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Why do the AAPI recommendations differ from the National CCS Antiplatelet and ESC guidelines if all of the committee\u2019s evaluated the same body of clinical evidence?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/DBZJLXKsnls?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">The AAPI Guideline primarily recommends a Selective vs. Universal approach with the newer antiplatelet medications, what considerations influenced that decision?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/IzbYcx9BAaw?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What are the key messages the Panel conveyed to Atlantic clinicians via the AAPI recommendation<\/a>s?<\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/qoN76ypguj0?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What is the Provincial payer stance on the AAPI recommendations?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-50  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-e81b1beb701b8db70beb5752dadb824a  avia-builder-el-51  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4156 avia-img-lazy-loading-not-4156 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/michael-scott.jpg\" alt='Michael Scott'  itemprop=\"image\"   height=\"360\" width=\"480\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/michael-scott.jpg 480w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/michael-scott-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/michael-scott-300x225.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Michael Scott<\/h3><div class='team-member-description '  itemprop=\"description\" ><p>Patient Representative<br \/>\nChairman of the Board<br \/>\nPrecision BioLogic.<br \/>\nDartmouth, Nova Scotia<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-52  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-e7eaf785cabfc598d5499b7f708d988e\">\n#top .av-special-heading.av-av_heading-e7eaf785cabfc598d5499b7f708d988e{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-e7eaf785cabfc598d5499b7f708d988e .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-e7eaf785cabfc598d5499b7f708d988e .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-e7eaf785cabfc598d5499b7f708d988e av-special-heading-h3  avia-builder-el-53  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Michael Scott<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/ipkw7mQYWu0?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How did you become involved with the AAPI Panel?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/VryLqSNbf1A?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What key insights did you observed during your participation in this guideline creation process?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/W-ZRavn7Tao?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">When reflecting upon the experience, what are the most relevant points you would share with the audience?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-55  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-3a92ef3f3d8d0cf348d9d1faf1e8b2c8  avia-builder-el-56  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4158 avia-img-lazy-loading-not-4158 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-scott-wilson.jpg\" alt='Scott Wilson'  itemprop=\"image\"   height=\"360\" width=\"480\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-scott-wilson.jpg 480w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-scott-wilson-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/dr-scott-wilson-300x225.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Scott Wilson<\/h3><div class='team-member-job-title '  itemprop=\"jobTitle\" > MD, CCFP (EM)<\/div><div class='team-member-description '  itemprop=\"description\" ><p>Emergency Room Physician<br \/>\nRegional Clinical Chief of Emergency Medicine and Performance (Eastern Health)<br \/>\nSt. John\u2019s, Newfoundland<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-57  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-773fca5e8319ac647d7ec371c28759bd\">\n#top .av-special-heading.av-av_heading-773fca5e8319ac647d7ec371c28759bd{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-773fca5e8319ac647d7ec371c28759bd .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-773fca5e8319ac647d7ec371c28759bd .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-773fca5e8319ac647d7ec371c28759bd av-special-heading-h3  avia-builder-el-58  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Scott Wilson<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/RQCENlrM1Yk?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">As an Emergency room physician, how would you characterize the process through which these recommendations were generated?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/h-MshYDA_JE?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How do these AAPI recommendations impact care within and between hospitals throughout Atlantic Canada<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/aRyXap0nuqU?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Considering the mortality benefit, why did the Panel not recommended a broader use of the newer antiplatelet agents such as ticagrelor in emergency departments throughout Atlantic Canada?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/tdMKRuiXd2c?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What are the key messages the Panel conveyed to Emergency Department Physicians via the AAPI recommendations?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-60  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-145bfaaf46551be851e6da6c2eba042a  avia-builder-el-61  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4160 avia-img-lazy-loading-not-4160 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/stephanie-young.jpg\" alt='Stephanie Young'  itemprop=\"image\"   height=\"360\" width=\"480\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/stephanie-young.jpg 480w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/stephanie-young-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/stephanie-young-300x225.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Stephanie Young<\/h3><div class='team-member-job-title '  itemprop=\"jobTitle\" >BSc. (Pharm), ACPR, PharmD., MSc. (Med)<\/div><div class='team-member-description '  itemprop=\"description\" ><p>BSc. (Pharm), ACPR, PharmD., MSc. (Med)<br \/>\nAssistant Professor, School of Pharmacy, Memorial University<br \/>\nClinical Pharmacotherapy Specialist, (Eastern Health) St. John\u2019s, Newfoundland<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-62  el_after_av_one_third  el_before_av_one_third  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-1090887951e64bdf9d84e12d6fd38c6d\">\n#top .av-special-heading.av-av_heading-1090887951e64bdf9d84e12d6fd38c6d{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-1090887951e64bdf9d84e12d6fd38c6d .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-1090887951e64bdf9d84e12d6fd38c6d .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-1090887951e64bdf9d84e12d6fd38c6d av-special-heading-h3  avia-builder-el-63  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Stephanie Young<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/PtNY5GOfGlM?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">As a Hospital Pharmacist, how would you describe the process through which these recommendations were generated?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/F_v3ncE0sYI?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How do the AAPI recommendations impact care within and between hospitals throughout Atlantic Canada<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/axPe8UD0pHI?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Considering the mortality benefit, why did the Panel not recommended a broader use of the newer antiplatelet agents such as ticagrelor in emergency departments throughout Atlantic Canada?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/ZuTBksxVNlE?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">Considering clopidogrel\u2019s established inter-patient variability, how confident was your Panel with recommending generic clopidogrel for Atlantic acute coronary syndrome patients?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/0Xl5KqHPGxk?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How do payers throughout Atlantic Canada view the AAPI recommendations?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n<div class='flex_column av-av_one_third-2a9015ff38129c418a3f2eafba3e9512 av_one_third  avia-builder-el-65  el_after_av_two_third  el_before_av_two_third  first flex_column_div column-top-margin'     ><section  class='avia-team-member av-av_team_member-d02a722e83e52592784a3d4fa058e090  avia-builder-el-66  avia-builder-el-no-sibling '  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\" ><div class=\"team-img-container\"><img decoding=\"async\" class='wp-image-4162 avia-img-lazy-loading-not-4162 avia_image avia_image_team' src=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/kevin-mckenzie.jpg\" alt='Kevin McKenzie'  itemprop=\"image\"   height=\"360\" width=\"480\" srcset=\"https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/kevin-mckenzie.jpg 480w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/kevin-mckenzie-450x338.jpg 450w, https:\/\/ac-society.org\/wp\/wp-content\/uploads\/2015\/01\/kevin-mckenzie-300x225.jpg 300w\" sizes=\"(max-width: 480px) 100vw, 480px\" \/><\/div><h3 class='team-member-name '  itemprop=\"name\" >Kevin McKenzie<\/h3><div class='team-member-description '  itemprop=\"description\" ><p>Kevin McKenzie<br \/>\nAAPI Project Manager<br \/>\nHalifax, Nova Scotia<\/p>\n<\/div><span class='hidden team-member-affiliation'  itemprop=\"affiliation\" >Atlantic Cardiovascular Society<\/span><\/section><\/div>\n<div class='flex_column av-av_two_third-3d629b6c2a646979d79593678077f00c av_two_third  avia-builder-el-67  el_after_av_one_third  avia-builder-el-last  flex_column_div column-top-margin'     ><p>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-av_heading-c4b5e279a3eb799a09b1478832ed36ba\">\n#top .av-special-heading.av-av_heading-c4b5e279a3eb799a09b1478832ed36ba{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-av_heading-c4b5e279a3eb799a09b1478832ed36ba .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-av_heading-c4b5e279a3eb799a09b1478832ed36ba .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-av_heading-c4b5e279a3eb799a09b1478832ed36ba av-special-heading-h3  avia-builder-el-68  el_before_av_textblock  avia-builder-el-first '><h3 class='av-special-heading-tag'  itemprop=\"headline\"  >Kevin McKenzie<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><br \/>\n<section  class='av_textblock_section av-av_textblock-0366cc7376be6c9e82a3e9cc8987b64f'  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><ol>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/wat-_SHjES4?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How did the project originate?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/NDTxlKt-Ly0?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How was the AAPI project funded?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/p5ckGel2BsY?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">How did the Panel composition represent the Atlantic Region?<\/a><\/li>\n<li><a href=\"http:\/\/www.youtube.com\/embed\/7RP_bJ3UHQw?autoplay=1&amp;wmode=transparent&amp;rel=0\" target=\"_blank\" rel=\"noopener\">What process was used to generate the AAPI recommendations?<\/a><\/li>\n<\/ol>\n<\/div><\/section><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":3370,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"","meta":{"_links_to":"","_links_to_target":""},"_links":{"self":[{"href":"https:\/\/ac-society.org\/wp\/wp-json\/wp\/v2\/pages\/4110"}],"collection":[{"href":"https:\/\/ac-society.org\/wp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ac-society.org\/wp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ac-society.org\/wp\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ac-society.org\/wp\/wp-json\/wp\/v2\/comments?post=4110"}],"version-history":[{"count":49,"href":"https:\/\/ac-society.org\/wp\/wp-json\/wp\/v2\/pages\/4110\/revisions"}],"predecessor-version":[{"id":4128,"href":"https:\/\/ac-society.org\/wp\/wp-json\/wp\/v2\/pages\/4110\/revisions\/4128"}],"up":[{"embeddable":true,"href":"https:\/\/ac-society.org\/wp\/wp-json\/wp\/v2\/pages\/3370"}],"wp:attachment":[{"href":"https:\/\/ac-society.org\/wp\/wp-json\/wp\/v2\/media?parent=4110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}